Skip to main content
Clinical Trials/JPRN-UMIN000022726
JPRN-UMIN000022726Completed未知

Investigation of method for prediction of therapeutic effect of infliximab initial therapy for inflammatory bowel disease - IPININ study

Ofuna Chuo Hospital0 sites20 target enrollmentStarted: June 14, 2016Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
13years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who are considered not suitable for Infliximab use due to contraindication or considerable risks such as hypersensitivity to Infliximab. Other than above mentioned criteria, patients who are judged inappropriate by the doctor.

Investigators

Similar Trials